½ÃÀ庸°í¼­
»óǰÄÚµå
1611482

¼¼°èÀÇ Æ°»ì Ä¡·á ½ÃÀå : Ä¡·á À¯Çü, Á¦Ç° À¯Çü, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Stretch Marks Treatment Market by Treatment Type (Chemical Peels, Laser Therapy, Microdermabrasion), Product Type (Over-the-counter (OTC) Treatments, Prescription-Based Treatments), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ư»ì Ä¡·á ½ÃÀåÀº 2023³â¿¡ 26¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 27¾ï 8,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.67%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 37¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ư»ì Ä¡·á´Â ÀÓ½Å, üÁß Áõ°¡, »çÃá±â µî¿¡ ¼ö¹ÝµÇ´Â ±Þ°ÝÇÑ ÇǺΠ½ÅÃà¿¡ ÀÇÇØ ÀϹÝÀûÀ¸·Î ¹ß»ýÇÏ´Â ¼±Á¶ÈçÀ¸·Îµµ ¾Ë·ÁÁø ½ºÆ®·¹Ä¡ ¸¶Å©ÀÇ ¿ÜÇüÀ» °³¼±Çϱâ À§ÇØ ¼³°èµÈ ´Ù¾çÇÑ Á¦Ç° ¹× Ä¡·á°¡ Æ÷ÇԵ˴ϴÙ.ÀÌ ½ÃÀå¿¡´Â ¿ÜºÎ Å©¸²°ú ¿¬°í, ·¹ÀÌÀú Ä¡·á, ¹Ì¼¼ ´Ù¸¶ºê·¹À̼Ç, ¹Ì¿ë ¼ö¼ú µîÀÌ Æ÷ÇԵ˴ϴÙ. ·çÇÁÄɾ Áß½ÃÇÏ´Â ¼ÒºñÀÚ Áõ°¡¿¡ ÀÇÇØ ÀÌ·¯ÇÑ Ä¡·áÀÇ Çʿ伺Àº °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÀǽÄÀÇ Çâ»ó, °³ÀÎÀÇ ¿Ü¸ð¿¡ ´ëÇÑ ÅõÀÚ Àǿ忡 ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. º´¿ø, ¿¹¹æ, Ä¡·á ¸ñÀûÀÇ È¨ ÄɾîÀÔ´Ï´Ù.´ë»óÀÌ µÇ´Â ÃÖÁ¾»ç¿ëÀÚ´Â »êÈÄÀÇ ¿©¼ºÀ¸·ÎºÎÅÍ ÇÇÆ®´Ï½º ¾ÖÈ£°¡, û¼Ò³â, üÁß º¯µ¿ÁßÀÇ °³ÀαîÁö Æø³Ð½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 26¾ï 9,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 27¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 37¾ï ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 4.67%

½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é Ä¡·á ¹æ¹ýÀÇ ±â¼úÀû Áøº¸, ½ÅÈï±¹ÀÇ ¼ÒºñÀÚ ±â¹Ý È®´ë, ¹Ì ±âÁØ¿¡ ´ëÇÑ ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâÀ¸·Î ¼ºÀåÀÌ Á¿ìµÇ´Â °ÍÀÌ ¹àÇôÁ³½À´Ï´Ù. Ä¡·á Çõ½Å°ú Ä¡·á ¼º°ú¸¦ ³ôÀ̱â À§ÇÑ AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕ¿¡ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ°¡ ÁغñµÇ¾î ÀÖ½À´Ï´Ù. ÁöÇâÀÇ ¼ÒºñÀÚÃþÀÇ È®´ë¿¡ ´ëÀÀÇϴ õ¿¬ ¼ÒÀ糪 ¿À°¡´ÐÀÇ Á¦Ç° ¶óÀο¡ ÁøÃâÇÏ´Â °ÍÀ¸·Î, ¹Ì°³Ã´ÀÇ ºÐ¾ß¸¦ °³Ã´ÇÒ ¼ö ÀÖ´Ù°í »ý°¢µË´Ï´Ù. ½Ã ¼ú¿¡ º¸ÇèÀÌ Àû¿ëµÇÁö ¾Ê´Â °Í, ºÎÀÛ¿ëÀÇ °¡´É¼ºÀÌ ÀÖ´Â °Í µîÀÇ Á¦¾àÀÌ ½ÃÀå È®´ë¿¡ ¹°À» ³¢Ä¡´Â °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù.

»õ·Î¿î ±â¼ú Çõ½ÅÀÇ ºÐ¾ß·Î´Â ȸº¹ ½Ã°£ÀÇ ´ÜÃà°ú È¿´ÉÀÇ Çâ»óÀ» ¾à¼ÓÇÏ´Â ¹ÙÀÌ¿À¿£Áö´Ï¾î¸µ ÇǺΠÁ¦Ç°À̳ª Àúħ½À ¼ö¼úÀÇ °³¹ßÀ» µé ¼ö ÀÖ½À´Ï´Ù. °æÀï ±¸µµÀÌÁö¸¸ ¿¬±¸ °³¹ß ¹× ¼ÒºñÀÚ ±³À° ÅõÀÚÇÏ·Á´Â ÀÇ¿åÀÌ ÀÖ´Â ±âÁ¸ ±â¾÷¿¡ À־´Â Å« ¼ºÀåÀÇ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ¸¶ÄÉÆÃ Àü·«, Áö¸®Àû È®´ë¿¡ ÁÖ·ÂÇØ¾ßÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ½Å¼ÓÇÏ°Ô ÁøÈ­Çϴ ư»ì Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ư»ì Ä¡·á ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¿ÇÁ Äɾî¿Í À̹ÌÁö ÁöÇâ Áõ°¡
    • ¼Ò¼È ¹Ìµð¾î, Ç÷§Æû°ú ¹Ì¿ë ±âÁØÀÇ °íÁ¶
    • ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­¿Í Àӽż±À» ÀÏÀ¸Å°´Â ´Ù¸¥ À§Çè ¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº Ä¡·áºñ
  • ½ÃÀå ±âȸ
    • ư»ì Ä¡·á ±â¼úÀÇ Áøº¸
    • Á¦Ç° Çõ½Å°ú Æø³ÐÀº Á¦Ç° ¶óÀξ÷
  • ½ÃÀåÀÇ °úÁ¦
    • ư»ì Ä¡·á¿¡ °üÇÑ ±âÁØÀ̳ª ±ÔÁ¦ÀÇ ºÎÁ·°ú ÇÑÁ¤ÀûÀÎ È¿°ú

Porter's Five Forces : ư»ì Ä¡·á ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ư»ì Ä¡·á ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ư»ì Ä¡·á ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ư»ì Ä¡·á ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ư»ì Ä¡·á ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ư»ì Ä¡·á ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ư»ì Ä¡·á ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå Æ°»ì Ä¡·á ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ư»ì Ä¡·á½ÃÀåÀÇ Àü·«ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¿ÇÁ Äɾî¿Í À̹ÌÁö ÀǽĿ¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁø´Ù
      • ¼ºÀåÇÏ´Â ¼Ò¼È ¹Ìµð¾î Ç÷§Æû°ú ¾Æ¸§´Ù¿òÀÇ ±âÁØ
      • ¶óÀÌÇÁ ½ºÅ¸ÀÏÀÇ º¯È­¿Í ½ºÆ®·¹Ä¡ ¸¶Å©¸¦ ÀÏÀ¸Å°´Â ´Ù¸¥ À§Çè ¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·áºñ°¡ ³ô´Ù
    • ±âȸ
      • ư»ì Ä¡·á ±â¼úÀÇ Áøº¸
      • Á¦Ç°ÀÇ Çõ½Å°ú Æø³ÐÀº Á¦Ç°ÀÇ Á¦°ø
    • °úÁ¦
      • ½ºÆ®·¹Ä¡ ¸¶Å© Ä¡·á¿¡ °üÇÑ ±âÁØÀ̳ª ±ÔÁ¦°¡ ºÎÁ·Çϰí, È¿°ú°¡ ÇÑÁ¤µÇ¾î ÀÖ´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Æ°»ì Ä¡·á ½ÃÀå : Ä¡·áÀ¯Çüº°

  • ÄɹÌÄà Çʸµ
  • ·¹ÀÌÀú Ä¡·á
  • ¹Ì¼¼¹ÚÇǼú
  • ´ÙÇ÷¼ÒÆÇ Ç÷Àå(PRP) ¿ä¹ý
  • °íÁÖÆÄ(RF) ¿ä¹ý
  • ¿Ü¿ë Å©¸²°ú ¿¬°í
    • Å©¸²
    • Á©
    • ·Î¼Ç
    • ¿ÀÀÏ

Á¦7Àå Æ°»ì Ä¡·á ½ÃÀå : Á¦Ç° À¯Çüº°

  • ½ÃÆÇ¾à(OTC)¿¡ ÀÇÇÑ Ä¡·á
  • ó¹æÀü¿¡ ±Ù°ÅÇÑ Ä¡·á

Á¦8Àå Æ°»ì Ä¡·á ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÇǺΰú Ŭ¸®´Ð°ú ¼¾ÅÍ
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø
  • °³ÀÎ
  • ½ºÆÄ ¹× À£´Ï½º ¼¾ÅÍ

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Æ°»ì Ä¡·á ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æ°»ì Ä¡·á ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æ°»ì Ä¡·á ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Alliance Pharma PLC
  • basq NYC
  • Bayer AG
  • Candela Corporation
  • Casmara Cosmetics SA
  • Clarins Pte Ltd.
  • Concord Medisys
  • Cynosure LLC
  • Dermaclara, LLC
  • ET Browne Drug Co. Inc.
  • Helix BioMedix, Inc.
  • HRA Pharma SAS
  • iHerb, LLC
  • Laboratoires Expanscience
  • Lumenis Be Ltd.
  • L'Oreal USA, Inc.
  • Merz Pharma GmbH & Co.KGaA
  • Perrigo Company PLC
  • Reliance Retail Limited
  • SOS Science of Skin Ltd.
  • Strialite
  • The Boppy Company, LLC
  • THG Beauty Limited
  • VLCC Health Care Limited
  • Weleda Inc.
BJH 24.12.24

The Stretch Marks Treatment Market was valued at USD 2.69 billion in 2023, expected to reach USD 2.78 billion in 2024, and is projected to grow at a CAGR of 4.67%, to USD 3.70 billion by 2030.

Stretch marks treatment encompasses a variety of products and procedures designed to reduce the appearance of stretch marks, also known as striae, which commonly occur due to rapid skin stretching associated with pregnancy, weight gain, or puberty. The market scope includes topical creams and ointments, laser therapy, microdermabrasion, and cosmetic surgery. Driven by a growing consumer emphasis on aesthetic appeal and self-care, the necessity for these treatments is fueled by rising disposable incomes, increased awareness, and a willingness to invest in personal appearance. Key applications are largely in dermatology clinics, hospitals, and home care for preventative and remedial purposes. Target end-users range from postpartum women to fitness enthusiasts, adolescents, and individuals undergoing weight fluctuations.

KEY MARKET STATISTICS
Base Year [2023] USD 2.69 billion
Estimated Year [2024] USD 2.78 billion
Forecast Year [2030] USD 3.70 billion
CAGR (%) 4.67%

Market insights reveal growth influenced by technological advances in treatment methods, expanding consumer bases in emerging economies, and the impact of social media on beauty standards. The sector is poised for potential opportunities, particularly in personalized treatment innovations and the integration of AI and machine learning for enhanced procedural outcomes. Additionally, market players could explore untapped areas by branching into natural and organic product lines which cater to a growing segment of health-conscious consumers. However, constraints such as the high cost of advanced treatments, lack of insurance coverage for cosmetic procedures, and potential side effects present challenges that dampen market expansion. Regulatory hurdles and the slower approval process for novel treatments can also act as barriers.

Emerging areas of innovation include development in bioengineered skin products and minimally invasive procedures, which promise reduced recovery time and improved efficacy. The nature of the market indicates a competitive landscape with a high entry barrier for new entrants but offers substantial growth potential for established companies willing to invest in R&D and consumer education. To harness growth, stakeholders should focus on strategic partnerships, effective marketing strategies, and geographic expansion to capitalize on the diverse demands of a global consumer base seeking effective stretch marks treatments.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stretch Marks Treatment Market

The Stretch Marks Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing focus on self-care and image consciousness
    • Growing social media platforms and beauty standards
    • Changing lifestyle and other risk factors causing stretch marks
  • Market Restraints
    • High treatment cost
  • Market Opportunities
    • Advancements in the stretch marks treatment technology
    • Product innovation and availability of a wide range of products
  • Market Challenges
    • Lack of standards and regulations for stretch mark treatments and limited effectiveness

Porter's Five Forces: A Strategic Tool for Navigating the Stretch Marks Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stretch Marks Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stretch Marks Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stretch Marks Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stretch Marks Treatment Market

A detailed market share analysis in the Stretch Marks Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stretch Marks Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stretch Marks Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stretch Marks Treatment Market

A strategic analysis of the Stretch Marks Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stretch Marks Treatment Market, highlighting leading vendors and their innovative profiles. These include Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Casmara Cosmetics SA, Clarins Pte Ltd., Concord Medisys, Cynosure LLC, Dermaclara, LLC, E.T. Browne Drug Co., Inc., Helix BioMedix, Inc., HRA Pharma SAS, iHerb, LLC, Laboratoires Expanscience, Lumenis Be Ltd., L'Oreal USA, Inc., Merz Pharma GmbH & Co.KGaA, Perrigo Company PLC, Reliance Retail Limited, SOS Science of Skin Ltd., Strialite, The Boppy Company, LLC, THG Beauty Limited, VLCC Health Care Limited, and Weleda Inc..

Market Segmentation & Coverage

This research report categorizes the Stretch Marks Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment Type, market is studied across Chemical Peels, Laser Therapy, Microdermabrasion, Platelet-Rich Plasma (PRP) Therapy, Radiofrequency (RF) Therapy, and Topical Creams & Ointments. The Topical Creams & Ointments is further studied across Creams, Gels, Lotions, and Oils.
  • Based on Product Type, market is studied across Over-the-counter (OTC) Treatments and Prescription-Based Treatments.
  • Based on End-User, market is studied across Dermatology Clinics & Centers, Homecare Settings, Hospitals, Individual, and Spas & Wellness Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing focus on self-care and image consciousness
      • 5.1.1.2. Growing social media platforms and beauty standards
      • 5.1.1.3. Changing lifestyle and other risk factors causing stretch marks
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the stretch marks treatment technology
      • 5.1.3.2. Product innovation and availability of a wide range of products
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standards and regulations for stretch mark treatments and limited effectiveness
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stretch Marks Treatment Market, by Treatment Type

  • 6.1. Introduction
  • 6.2. Chemical Peels
  • 6.3. Laser Therapy
  • 6.4. Microdermabrasion
  • 6.5. Platelet-Rich Plasma (PRP) Therapy
  • 6.6. Radiofrequency (RF) Therapy
  • 6.7. Topical Creams & Ointments
    • 6.7.1. Creams
    • 6.7.2. Gels
    • 6.7.3. Lotions
    • 6.7.4. Oils

7. Stretch Marks Treatment Market, by Product Type

  • 7.1. Introduction
  • 7.2. Over-the-counter (OTC) Treatments
  • 7.3. Prescription-Based Treatments

8. Stretch Marks Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dermatology Clinics & Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals
  • 8.5. Individual
  • 8.6. Spas & Wellness Centers

9. Americas Stretch Marks Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stretch Marks Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stretch Marks Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alliance Pharma PLC
  • 2. basq NYC
  • 3. Bayer AG
  • 4. Candela Corporation
  • 5. Casmara Cosmetics SA
  • 6. Clarins Pte Ltd.
  • 7. Concord Medisys
  • 8. Cynosure LLC
  • 9. Dermaclara, LLC
  • 10. E.T. Browne Drug Co., Inc.
  • 11. Helix BioMedix, Inc.
  • 12. HRA Pharma SAS
  • 13. iHerb, LLC
  • 14. Laboratoires Expanscience
  • 15. Lumenis Be Ltd.
  • 16. L'Oreal USA, Inc.
  • 17. Merz Pharma GmbH & Co.KGaA
  • 18. Perrigo Company PLC
  • 19. Reliance Retail Limited
  • 20. SOS Science of Skin Ltd.
  • 21. Strialite
  • 22. The Boppy Company, LLC
  • 23. THG Beauty Limited
  • 24. VLCC Health Care Limited
  • 25. Weleda Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦